← Back to Analyst Consensus 
ALLR Buy
Allarity Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 14, 2026 (19 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 16, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Jun 8, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Apr 10, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 9, 2025 | Ascendiant Capital | maintain | Buy → Buy | $9.5 | 38% |
| Sep 26, 2025 | Ascendiant Capital | maintain | Buy → Buy | $9.25 | 38% |
| Jul 28, 2025 | Ascendiant Capital | initiate | — → Buy | $9 | 38% |
Price Target Trend
Apr 30, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days